DR3
TNFRSF25 (TNF Receptor Superfamily Member 25) is a member of the TNF-receptor superfamily. This receptor is expressed preferentially in the tissues enriched in lymphocytes, and it may play a role in regulating lymphocyte homeostasis. This receptor has been shown to stimulate NF-kappa B activity and regulate cell apoptosis. The signal transduction of this receptor is mediated by various death domain containing adaptor proteins. Knockout studies in mice suggested the role of this gene in the removal of self-reactive T cells in the thymus. Multiple alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported, most of which are potentially secreted molecules. The alternative splicing of this gene in B and T cells encounters a programmed change upon T-cell activation, which predominantly produces full-length, membrane bound isoforms, and is thought to be involved in controlling lymphocyte proliferation induced by T-cell activation.CAT | Product Name | Source | Product Overview | Target | Type | Datasheet | Size | Price |
---|---|---|---|---|---|---|---|---|
VAng-1471Lsx | Recombinant DR3 Protein (Gln 20-Gly 203) [Fc] | HEK293 Cells. | Cynomolgus DR3 (TNFRSF25), Fc tag, is expressed in HEK 293 cells. (Uniprot ID: G7NTB5) | DR3 | Tumor Antigens | ![]() |
100 µg | Inquiry |
VAng-1472Lsx | Recombinant DR3 Protein (Gln 25-Gln 199) [Fc] | HEK293 Cells. | Human DR3 (TNFRSF25), Fc tag, is expressed in HEK 293 cells. (Uniprot ID: AAI17190) | DR3 | Tumor Antigens | ![]() |
100 µg | Inquiry |
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.